微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 8.57% | 15.81% | 42.36% | 6/52 | 3.3% | 澳洋健康 | 25.95% | 行业排名> |
| 2025-06-30 | 6.02% | 10.46% | 108.3% | 6/52 | 1.68% | 澳洋健康 | 19.74% | 行业排名> |
| 2025-03-31 | 2.89% | 4.33% | -58.89% | 5/52 | 0.99% | 澳洋健康 | 12.87% | 行业排名> |
| 2024-12-31 | 7.03% | -45.96% | -5% | 9/52 | -1.11% | 澳洋健康 | 28.53% | 行业排名> |
| 2024-09-30 | 7.4% | -40.13% | 35.78% | 8/52 | 3.33% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 5.45% | -32.38% | 96.75% | 6/52 | 1.9% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 2.77% | -29.87% | -78.71% | 7/52 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 13.01% | -30.83% | 5.26% | 7/52 | 2.79% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 12.36% | -19.06% | 53.35% | 10/52 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 8.06% | -17.76% | 104.05% | 10/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 3.95% | -11.04% | -79% | 10/52 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 18.81% | 38.11% | 23.18% | 12/52 | -1.81% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 15.27% | 33.6% | 55.82% | 15/52 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 9.8% | 60.39% | 120.72% | 13/52 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 4.44% | 78.31% | -67.4% | 10/52 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 13.62% | 24.84% | 19.16% | 21/52 | -7.44% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 11.43% | 42.16% | 87.07% | 16/52 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 6.11% | 46.17% | 145.38% | 22/52 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 2.49% | 120.35% | -77.18% | 19/52 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 10.91% | 33.7% | 35.7% | 27/52 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 8.04% | 64.08% | 92.34% | 16/52 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 4.18% | 27.44% | 269.91% | 18/52 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 1.13% | -27.1% | -86.15% | 16/52 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 8.16% | 24.2% | 66.53% | 31/52 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 4.9% | 36.87% | 49.39% | 19/52 | 10.68% | *ST生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 3.28% | -12.77% | 111.61% | 17/52 | 5.65% | *ST生物 | 98.98% | 行业排名> |
| 2019-03-31 | 1.55% | -18.85% | -76.41% | 17/52 | 3.54% | *ST生物 | 82.46% | 行业排名> |
| 2018-12-31 | 6.57% | 24.9% | 83.52% | 29/52 | -0.6% | *ST生物 | 48.41% | 行业排名> |
| 2018-09-30 | 3.58% | -18.26% | -4.79% | 19/52 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 3.76% | 39.78% | 96.86% | 15/52 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.91% | 17.18% | -63.69% | 10/52 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 5.26% | 39.89% | 20.09% | 26/52 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 4.38% | 28.45% | 62.83% | 19/52 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 2.69% | 126.05% | 65.03% | 20/52 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 1.63% | 9.4% | -56.65% | 14/52 | -5.59% | *ST生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 3.76% | -59.4% | 10.26% | 24/52 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 3.41% | -66.7% | 186.55% | 13/52 | 5.93% | *ST生物 | 383.03% | 行业排名> |
| 2016-06-30 | 1.19% | -71.6% | -20.13% | 17/52 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 1.49% | -41.11% | -83.91% | 11/52 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 9.26% | -20.1% | -9.57% | 17/52 | 22.23% | *ST生物 | 55.01% | 行业排名> |
| 2015-09-30 | 10.24% | -27.63% | 144.39% | 7/52 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 4.19% | -50.94% | 65.61% | 9/52 | -30.81% | *ST生物 | 24.73% | 行业排名> |
| 2015-03-31 | 2.53% | 2% | -78.17% | 8/52 | -5.77% | *ST生物 | 400.84% | 行业排名> |